Status:
UNKNOWN
Effect of Transfusion of Plasma on Endothelial During Liver Transplantation
Lead Sponsor:
Beijing Chao Yang Hospital
Conditions:
End Stage Liver DIsease
Liver Transplantation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
To study the effects of plasma transfusionon during liver transplantation on endothelial condition and short-term outcome in patients with end-stage liver disease.
Eligibility Criteria
Inclusion
- Child A/B cirrhosis
- patients who undergo the first OLT
- Informed and consented
- complete follow-up
- cooperate with treatment
Exclusion
- re-transplant
- combined liver and other organ transplantation
- BMI≥30Kg/m2
- patients with hypertension, diabetes, coronary heart disease, chronic renal insufficiency, preoperative pulmonary infection, pleural effusion
- acute liver failure
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04107883
Start Date
October 1 2023
End Date
December 31 2024
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital Medical University Affiliated Beijing Chaoyang Hospital
Beijing, Beijing Municipality, China, 100020